Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions
Open Access
- 25 August 2000
- Vol. 90 (4) , 230-234
- https://doi.org/10.1002/1097-0142(20000825)90:4<230::aid-cncr5>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- E-cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthlessDiagnostic Cytopathology, 1999
- Diagnostic utility of sialosyl-Tn in discriminating carcinomatous cells from benign mesothelium in body cavity effusions.Acta Cytologica, 1999
- Detection of K-rasPoint Mutations in the Supernatants of Peritoneal and Pleural Effusions for Diagnosis Complementary to Cytologic ExaminationAmerican Journal of Clinical Pathology, 1998
- The Role of Conventional Cytology, Immunocytochemistry, and Flow Cytometric DNA Ploidy in the Evaluation of Body Cavity Fluids:A Prospective Study of 52 PatientsAmerican Journal of Clinical Pathology, 1998
- A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumoursHistopathology, 1998
- Value of the Ber-EP4 Antibody in Differentiating Epithelial Pleural Mesothelioma From Adenocarcinoma:The M.D. Anderson Experience and a Critical Review of the LiteratureAmerican Journal of Clinical Pathology, 1998
- Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patientsBritish Journal of Cancer, 1997
- Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.Thorax, 1994
- Nucleolar organiser regions of mesothelial and carcinomatous cells in effusionsDiagnostic Cytopathology, 1993
- The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patientsSurgery Today, 1991